|
US3272824A
(en)
|
1962-12-06 |
1966-09-13 |
Norwich Pharma Co |
4-amino-6, 7-di(lower) alkoxyquinolines
|
|
US3266990A
(en)
|
1963-09-24 |
1966-08-16 |
Warner Lambert Pharmaceutical |
Derivatives of quinazoline
|
|
US3936461A
(en)
|
1973-09-24 |
1976-02-03 |
Warner-Lambert Company |
Substituted 4-benzylquinolines
|
|
US4114939A
(en)
|
1976-09-13 |
1978-09-19 |
Conco Inc. |
Vacuum pickup head
|
|
IL89029A
(en)
|
1988-01-29 |
1993-01-31 |
Lilly Co Eli |
Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
|
|
IL89028A0
(en)
|
1988-01-29 |
1989-08-15 |
Lilly Co Eli |
Quinoline,quinazoline and cinnoline derivatives
|
|
IL89027A
(en)
|
1988-01-29 |
1993-01-31 |
Lilly Co Eli |
Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
|
|
WO1990005523A2
(en)
|
1988-11-15 |
1990-05-31 |
The Upjohn Company |
Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
|
|
US5034393A
(en)
*
|
1989-07-27 |
1991-07-23 |
Dowelanco |
Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
|
|
WO1992017452A1
(en)
|
1991-04-03 |
1992-10-15 |
Korea Research Institute Of Chemical Technology |
2-quinolinone derivatives
|
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
|
JPH05213884A
(ja)
|
1991-06-14 |
1993-08-24 |
Upjohn Co:The |
新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
|
|
NZ243082A
(en)
|
1991-06-28 |
1995-02-24 |
Ici Plc |
4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
GB9300059D0
(en)
|
1992-01-20 |
1993-03-03 |
Zeneca Ltd |
Quinazoline derivatives
|
|
DE4208254A1
(de)
|
1992-03-14 |
1993-09-16 |
Hoechst Ag |
Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid
|
|
US5326766A
(en)
*
|
1992-08-19 |
1994-07-05 |
Dreikorn Barry A |
4-(2-(4-(2-pyridinyloxy)phenyl)ethoxy)quinazoline and analogues thereof
|
|
AU4790893A
(en)
|
1992-08-19 |
1994-03-15 |
Dowelanco |
Pyridylethoxy-, pyridylethylamino-, and pyridylpropyl-derivatives of quinoline and quinazoline as insecticides and fungicides
|
|
GB9314893D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Quinazoline derivatives
|
|
GB9314884D0
(en)
|
1993-07-19 |
1993-09-01 |
Zeneca Ltd |
Tricyclic derivatives
|
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
|
GB9510757D0
(en)
|
1994-09-19 |
1995-07-19 |
Wellcome Found |
Therapeuticaly active compounds
|
|
US5650415A
(en)
|
1995-06-07 |
1997-07-22 |
Sugen, Inc. |
Quinoline compounds
|
|
WO1996040648A1
(en)
|
1995-06-07 |
1996-12-19 |
Sugen, Inc. |
Quinazolines and pharmaceutical compositions
|
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
|
US6143764A
(en)
|
1995-11-07 |
2000-11-07 |
Kirin Beer Kabushiki Kaisha |
Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same
|
|
JP4471404B2
(ja)
|
1996-02-13 |
2010-06-02 |
アストラゼネカ ユーケイ リミテッド |
Ｖｅｇｆインヒビターとしてのキナゾリン誘導体
|
|
EP0912559B1
(en)
|
1996-07-13 |
2002-11-06 |
Glaxo Group Limited |
Fused heterocyclic compounds as protein tyrosine kinase inhibitors
|
|
IL128994A
(en)
|
1996-09-25 |
2004-12-15 |
Zeneca Ltd |
History of quinoline and naphthyridine and their salts, processes for their preparation, pharmaceutical preparations containing them and their use as medicines
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
US6002008A
(en)
|
1997-04-03 |
1999-12-14 |
American Cyanamid Company |
Substituted 3-cyano quinolines
|
|
US6251912B1
(en)
|
1997-08-01 |
2001-06-26 |
American Cyanamid Company |
Substituted quinazoline derivatives
|
|
WO1999031072A1
(en)
|
1997-12-18 |
1999-06-24 |
E.I. Du Pont De Nemours And Company |
Cyclohexylamine arthropodicides and fungicides
|
|
DE69917201T2
(de)
*
|
1998-07-22 |
2005-05-04 |
Daiichi Suntory Pharma Co., Ltd. |
Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten
|
|
US6297258B1
(en)
|
1998-09-29 |
2001-10-02 |
American Cyanamid Company |
Substituted 3-cyanoquinolines
|
|
ES2241324T3
(es)
|
1998-10-08 |
2005-10-16 |
Astrazeneca Ab |
Derivados de quinazolina.
|
|
ES2208261T3
(es)
|
1999-01-22 |
2004-06-16 |
Kirin Beer Kabushiki Kaisha |
Derivados de quinolina y derivados de quinazolina.
|
|
PL205557B1
(pl)
|
1999-02-10 |
2010-05-31 |
Astrazeneca Ab |
Pochodne indolu
|
|
GB9904103D0
(en)
|
1999-02-24 |
1999-04-14 |
Zeneca Ltd |
Quinoline derivatives
|
|
GB9910577D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
GB9910580D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
GB9910579D0
(en)
|
1999-05-08 |
1999-07-07 |
Zeneca Ltd |
Chemical compounds
|
|
IL148576A0
(en)
|
1999-09-21 |
2002-09-12 |
Astrazeneca Ab |
Quinazoline derivatives and their use as pharmaceuticals
|
|
US7081461B1
(en)
|
1999-09-21 |
2006-07-25 |
Astrazeneca Ab |
Quinazoline compounds and pharmaceutical compositions containing them
|
|
GB9930061D0
(en)
|
1999-12-20 |
2000-02-09 |
Glaxo Group Ltd |
Quinolone compounds for use in treating viral infections
|
|
WO2001047890A1
(en)
|
1999-12-24 |
2001-07-05 |
Kirin Beer Kabushiki Kaisha |
Quinoline and quinazoline derivatives and drugs containing the same
|
|
US6906063B2
(en)
|
2000-02-04 |
2005-06-14 |
Portola Pharmaceuticals, Inc. |
Platelet ADP receptor inhibitors
|
|
PT1274692E
(pt)
|
2000-04-07 |
2006-11-30 |
Astrazeneca Ab |
Compostos de quinazolina
|
|
EE200200715A
(et)
|
2000-06-28 |
2004-08-16 |
Astrazeneca Ab |
Asendatud kinasoliini derivaadid ja nende kasutamine inhibiitoritena
|
|
DE10042064A1
(de)
|
2000-08-26 |
2002-03-07 |
Boehringer Ingelheim Pharma |
Chinazoline, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
|
EP1337524A1
(en)
|
2000-11-02 |
2003-08-27 |
AstraZeneca AB |
Substituted quinolines as antitumor agents
|
|
ES2312557T3
(es)
|
2001-04-19 |
2009-03-01 |
Astrazeneca Ab |
Derivados de quinazolina.
|
|
ES2256466T3
(es)
|
2001-04-27 |
2006-07-16 |
Kirin Beer Kabushiki Kaisha |
Derivado de quinolina que tienen grupo azolilo y derivados de quinazolina.
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
CA2454538A1
(en)
|
2001-06-22 |
2003-01-03 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
|
|
DE60215178T2
(de)
|
2001-07-16 |
2007-08-23 |
Astrazeneca Ab |
Quinolin-derivate und ihre verwendung als inhibitoren der tyrosine kinase
|
|
EP1447405A4
(en)
|
2001-10-17 |
2005-01-12 |
Kirin Brewery |
CHINOLIN OR CHINAZOLINE DERIVATIVES THAT PREVENT THE AUTOPHOSPHORYLATION OF RECEPTORS FOR THE FIBROBLAST GROWTH FACTOR
|
|
JP2005518365A
(ja)
|
2001-11-27 |
2005-06-23 |
メルク エンド カムパニー インコーポレーテッド |
４−アミノキノリン化合物
|
|
WO2003047584A1
(en)
|
2001-12-05 |
2003-06-12 |
Astrazeneca Ab |
Quinoline derivatives
|
|
AU2002365664A1
(en)
|
2001-12-05 |
2003-06-17 |
Astrazeneca Ab |
Quinoline derivatives as antitumour agents
|
|
GB0129099D0
(en)
|
2001-12-05 |
2002-01-23 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2003047583A1
(en)
|
2001-12-05 |
2003-06-12 |
Astrazeneca Ab |
Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours
|
|
AU2002347336A1
(en)
|
2001-12-05 |
2003-06-17 |
Astrazeneca Ab |
Quinoline derivatives
|
|
AU2002347360A1
(en)
|
2001-12-05 |
2003-06-17 |
Astrazeneca Ab |
Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours
|
|
AU2002361846A1
(en)
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
|
RU2362775C1
(ru)
|
2002-02-01 |
2009-07-27 |
Астразенека Аб |
Хиназолиновые соединения
|
|
US7598258B2
(en)
|
2002-05-01 |
2009-10-06 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives inhibiting autophosphorylation of macrophage colony stimulating factor receptor
|
|
DE10221018A1
(de)
|
2002-05-11 |
2003-11-27 |
Boehringer Ingelheim Pharma |
Verwendung von Hemmern der EGFR-vermittelten Signaltransduktion zur Behandlung von gutartiger Prostatahyperplasie (BPH)/Prostatahypertrophie
|
|
MY140680A
(en)
|
2002-05-20 |
2010-01-15 |
Bristol Myers Squibb Co |
Hepatitis c virus inhibitors
|
|
US7504408B2
(en)
|
2002-07-09 |
2009-03-17 |
Astrazeneca Ab |
Quinzoline derivatives for use in the treatment of cancer
|
|
GB0215823D0
(en)
|
2002-07-09 |
2002-08-14 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
EP2280003B1
(en)
|
2002-07-15 |
2014-04-02 |
Symphony Evolution, Inc. |
Process for preparing receptor-type kinase modulators
|
|
EP1548008A4
(en)
|
2002-08-23 |
2008-08-06 |
Kirin Pharma Kk |
COMPOUND WITH TGF-BETA-HEMMENDER EFFECT AND THIS MEDICAL COMPOSITION CONTAINING
|
|
EP1566379A4
(en)
|
2002-10-29 |
2005-11-09 |
Kirin Brewery |
CHINOLINE DERIVATIVES AND CHINAZOLINE DERIVATIVES AS INHIBITORS OF FLT3 AUTOPHOSPHORYLATION AND THE MEDICAL COMPOSITIONS CONTAINING THEREOF
|
|
GB0225579D0
(en)
|
2002-11-02 |
2002-12-11 |
Astrazeneca Ab |
Chemical compounds
|
|
DE60319410T2
(de)
|
2002-11-04 |
2009-02-19 |
Astrazeneca Ab |
Chinazolinderivate als src-tyrosinkinaseinhibitoren
|
|
JO2785B1
(en)
|
2003-05-27 |
2014-03-15 |
شركة جانسين فارماسوتيكا ان. في |
Quinazoline derivatives
|
|
ATE440825T1
(de)
*
|
2003-06-06 |
2009-09-15 |
Vertex Pharma |
Pyrimidin-derivate zur verwendung als modulatoren von atp-bindende kassette transportern
|
|
CN1838950A
(zh)
*
|
2003-06-23 |
2006-09-27 |
神经化学（国际）有限公司 |
治疗蛋白质聚集疾病的方法
|
|
US20050026805A1
(en)
|
2003-07-14 |
2005-02-03 |
Ici Americas, Inc. |
Solvated nonionic surfactants and fatty acids
|
|
GB0318422D0
(en)
|
2003-08-06 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0322722D0
(en)
|
2003-09-27 |
2003-10-29 |
Glaxo Group Ltd |
Compounds
|
|
JP4936897B2
(ja)
|
2003-12-18 |
2012-05-23 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗増殖剤としてのピリド−およびピリミドピリミジン誘導体
|
|
UA83880C2
(en)
|
2003-12-18 |
2008-08-26 |
Янссен Фармацевтика Н.В. |
3-cyano-quinoline derivatives with antiproliferative activity
|
|
GEP20084572B
(en)
|
2003-12-23 |
2008-12-25 |
Pfizer |
Novel quinoline derivatives
|
|
UA85698C2
(ru)
|
2004-01-16 |
2009-02-25 |
Уайет |
Хинолиновые промежуточные соединения для синтеза ингибиторов рецепторной тирозинкиназы и способ их получения
|
|
PT1854789E
(pt)
|
2005-02-23 |
2013-10-23 |
Shionogi & Co |
Derivado de quinazolina possuindo actividade inibidora de tirosina-cinase
|
|
AU2006224605B2
(en)
*
|
2005-03-14 |
2012-03-01 |
Aniona Aps |
Potassium channel modulating agents and their medical use
|
|
CN101115736A
(zh)
*
|
2005-03-14 |
2008-01-30 |
神经研究公司 |
钾通道调节剂和它们的医药用途
|
|
EP1874759A4
(en)
|
2005-04-06 |
2009-07-15 |
Exelixis Inc |
C-MET MODULATORS MODULATORS AND METHODS OF USE
|
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
|
US20090221624A1
(en)
|
2005-05-06 |
2009-09-03 |
Olivo Paul D |
4-aminoquinoline compounds for treating virus-related conditions
|
|
KR101353763B1
(ko)
|
2005-11-07 |
2014-01-21 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
혈관 신생 저해 물질과 ｃ―ｋｉｔ 키나아제 저해 물질의병용
|
|
WO2007055513A1
(en)
|
2005-11-08 |
2007-05-18 |
Hanmi Pharm. Co., Ltd. |
Quinazoline derivatives as a signal transduction inhibitor and method for the preparation thereof
|
|
CA2833706C
(en)
|
2005-11-11 |
2014-10-21 |
Boehringer Ingelheim International Gmbh |
Quinazoline derivatives for the treatment of cancer diseases
|
|
US7763731B2
(en)
|
2005-12-21 |
2010-07-27 |
Abbott Laboratories |
Anti-viral compounds
|
|
SI1981863T1
(sl)
|
2006-01-26 |
2013-01-31 |
Boehringer Ingelheim International Gmbh |
Postopek za pripravo aminokrotonilamino-substituiranih kinazolinskih derivatov
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
WO2008006050A2
(en)
|
2006-07-07 |
2008-01-10 |
Govek Steven P |
Bicyclic heteroaryl inhibitors of pde4
|
|
US8673929B2
(en)
|
2006-07-20 |
2014-03-18 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections
|
|
EP2061466A4
(en)
|
2006-08-23 |
2010-12-29 |
Xtl Biopharmaceuticals Ltd |
4-THIO-SUBSTITUTED CHINOLINE AND NAPHTHYRIDEIN COMPOUNDS
|
|
CN101558070A
(zh)
*
|
2006-10-23 |
2009-10-14 |
Sgx药品公司 |
三唑并哒嗪蛋白激酶调节剂
|
|
MX2009008531A
(es)
|
2007-02-16 |
2009-08-26 |
Amgen Inc |
Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
|
|
US8163923B2
(en)
|
2007-03-14 |
2012-04-24 |
Advenchen Laboratories, Llc |
Spiro substituted compounds as angiogenesis inhibitors
|
|
US8148532B2
(en)
|
2007-03-14 |
2012-04-03 |
Guoqing Paul Chen |
Spiro substituted compounds as angiogenesis inhibitors
|
|
DE102007032739A1
(de)
|
2007-07-13 |
2009-01-15 |
Merck Patent Gmbh |
Chinazolinamidderivate
|
|
CA2691450A1
(en)
|
2007-08-22 |
2009-02-26 |
Abbott Gmbh & Co. Kg |
4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
|
|
US8143276B2
(en)
|
2007-08-22 |
2012-03-27 |
Xtl Biopharmaceuticals Ltd. |
4-thio substituted quinoline and naphthyridine compounds
|
|
UA101010C2
(ru)
|
2008-01-18 |
2013-02-25 |
Натко Фарма Лимитед |
Производное 6,7-диалкоксихиназолина, пригодное для лечения расстройств, связанных с раком
|
|
WO2009148659A2
(en)
|
2008-03-05 |
2009-12-10 |
Georgetown University |
Antimalarial quinolines and methods of use thereof
|
|
PT2268623E
(pt)
|
2008-03-17 |
2015-09-17 |
Ambit Biosciences Corp |
Derivados de quinazolina como moduladores de cinase raf e métodos para utilização dos mesmos
|
|
US7829574B2
(en)
|
2008-05-09 |
2010-11-09 |
Hutchison Medipharma Enterprises Limited |
Substituted quinazoline compounds and their use in treating angiogenesis-related diseases
|
|
CA2727103A1
(en)
|
2008-07-03 |
2010-01-07 |
Merck Patent Gmbh |
Naphthyridinones as aurora kinase inhibitors
|
|
WO2010018555A2
(en)
|
2008-08-14 |
2010-02-18 |
University Of Cape Town |
Quinoline compounds containing a dibemethin group
|
|
US8268843B2
(en)
|
2008-08-29 |
2012-09-18 |
Dow Agrosciences, Llc. |
5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals
|
|
IT1393351B1
(it)
|
2009-03-16 |
2012-04-20 |
Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa |
Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi
|
|
US20120142929A1
(en)
|
2009-03-19 |
2012-06-07 |
Boehringer Ingelheim International Gmbh |
Process for preparing sulfonyl quinolines
|
|
JP5583751B2
(ja)
|
2009-03-21 |
2014-09-03 |
クイ ニング |
アミノエステル誘導体、その塩、及び使用方法
|
|
ES2353093B1
(es)
*
|
2009-05-20 |
2012-01-03 |
Consejo Superior De Investigaciones Científicas (Csic) |
Uso de derivados de quinazolinas y sus composiciones farmacéuticas en enfermedades neurodegenerativas.
|
|
AU2010265932B2
(en)
|
2009-06-25 |
2014-11-20 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
PH12012500097A1
(en)
*
|
2009-07-21 |
2011-01-27 |
Shanghai Inst Organic Chem |
Potent small molecule inhibitors of autophagy, and methods of use thereof
|
|
WO2011014039A1
(en)
*
|
2009-07-31 |
2011-02-03 |
Rohm And Haas Electronic Materials Korea Ltd. |
Novel organic electroluminescent compounds and organic electroluminescent device using the same
|
|
VN32513A1
(en)
|
2010-01-04 |
2013-02-25 |
Nippon Soda Co |
Nitrogen-containing heterocyclic compound and agricultural fungicide
|
|
US8575203B2
(en)
|
2010-04-21 |
2013-11-05 |
Boehringer Ingelheim International Gmbh |
Chemical compounds
|
|
WO2011143444A2
(en)
*
|
2010-05-14 |
2011-11-17 |
President And Fellows Of Harvard College |
Diphenylbutypiperidine autophagy inducers
|
|
MX2012015143A
(es)
|
2010-06-30 |
2013-07-03 |
Amgen Inc |
Compuestos heterociclicos que contienen nitrogeno como inhibidores de pi3k delta.
|
|
WO2012012320A1
(en)
*
|
2010-07-19 |
2012-01-26 |
Millenium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
|
UY33549A
(es)
|
2010-08-10 |
2012-01-31 |
Glaxo Group Ltd |
Quinolil aminas como agentes inhibidores de las quinasas
|
|
WO2012044993A1
(en)
*
|
2010-09-30 |
2012-04-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds, pharmaceutical compositions, and methods of treating or preventing neurodegenerative diseases or disorders
|
|
CA2818903C
(en)
*
|
2010-12-14 |
2021-03-23 |
Electrophoretics Limited |
5-(1,3-benzoxazol-2-yl)-4-(pyridin-4-yl)pyrimidin-2-amine and its use as a casein kinase 1delta inhibitor
|
|
WO2012090179A2
(en)
*
|
2010-12-30 |
2012-07-05 |
Lupin Limited |
Isoquinoline derivatives as cannabinoid receptor modulators
|
|
ES2609578T3
(es)
|
2011-03-04 |
2017-04-21 |
Glaxosmithkline Intellectual Property Development Limited |
Amino-quinolinas como inhibidores de quinasa
|
|
US8664230B2
(en)
*
|
2011-03-17 |
2014-03-04 |
The Asan Foundation |
Pyridopyrimidine derivatives and use thereof
|
|
ITMI20110480A1
(it)
|
2011-03-25 |
2012-09-26 |
F I S Fabbrica Italiana Sint P A |
Procedimento per la preparazione di lapatinib e suoi sali
|
|
AU2012284088B2
(en)
*
|
2011-07-19 |
2015-10-08 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
|
CN103958497B
(zh)
|
2011-11-14 |
2017-09-01 |
亚尼塔公司 |
作为AXL和c‑MET激酶抑制剂的尿嘧啶衍生物
|
|
CN102643268B
(zh)
|
2011-12-30 |
2014-05-21 |
沈阳药科大学 |
喹啉类及噌啉类化合物及其应用
|
|
EP2828250B1
(en)
|
2012-03-19 |
2021-03-10 |
Imperial College Innovations Limited |
Quinazoline compounds and their use in therapy
|
|
US9193718B2
(en)
|
2012-03-26 |
2015-11-24 |
Fujian Institute Of Research On The Structure Of Matter, Chinese Academy Of Sciences |
Quinazoline derivative and application thereof
|
|
TW201425307A
(zh)
|
2012-09-13 |
2014-07-01 |
Glaxosmithkline Llc |
作為激酶抑制劑之胺基－喹啉類
|
|
US9024023B2
(en)
|
2013-01-14 |
2015-05-05 |
F.I.S.—Fabbrica Italiana Sintetici S.p.A. |
Efficient process for the preparation of lapatinib and salts thereof by means of new intermediates
|
|
CA2900652C
(en)
|
2013-02-15 |
2021-05-04 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
|
CA2905417A1
(en)
|
2013-03-15 |
2014-09-18 |
Rexahn Pharmaceuticals, Inc. |
Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl) methanone compounds as cancer cell growth inhibitors
|
|
CN103232401B
(zh)
*
|
2013-04-12 |
2015-11-04 |
浙江工业大学 |
一种4-芳硫基喹唑啉类化合物的合成方法
|
|
EP2994140A4
(en)
|
2013-05-07 |
2017-05-03 |
Inhibikase Therapeutics, Inc. |
Methods for treating hcv infection
|
|
NO2998296T3
(cg-RX-API-DMAC10.html)
|
2013-05-13 |
2018-08-11 |
|
|
|
CN105916506B
(zh)
|
2013-11-20 |
2020-01-07 |
圣诺康生命科学公司 |
作为tam家族激酶抑制剂的喹唑啉衍生物
|
|
GB201321146D0
(en)
|
2013-11-29 |
2014-01-15 |
Cancer Rec Tech Ltd |
Quinazoline compounds
|
|
GB201321126D0
(en)
*
|
2013-11-29 |
2014-01-15 |
Velgene Biotechnology |
Autophagy stimulants
|
|
EP3091984B1
(en)
*
|
2014-01-09 |
2020-04-22 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Substituted benzoxazine and related compounds
|
|
SG11201607973XA
(en)
|
2014-03-24 |
2016-11-29 |
Guangdong Zhongsheng Pharmaceutical Co Ltd |
Quinoline derivatives as smo inhibitors
|
|
FR3019819B1
(fr)
|
2014-04-09 |
2018-03-23 |
Centre National De La Recherche Scientifique (Cnrs) |
Composes cytotoxiques inhibiteurs de la polymerisation de la tubuline
|
|
US20150329498A1
(en)
|
2014-04-22 |
2015-11-19 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
CN104193728A
(zh)
*
|
2014-08-26 |
2014-12-10 |
北京大学深圳研究生院 |
流感病毒抑制剂及其应用
|
|
KR20180086187A
(ko)
*
|
2015-10-05 |
2018-07-30 |
더 트러스티이스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 |
자가포식 유동의 활성체 및 포스포리파제 d 및 타우를 포함하는 단백질 응집물의 클리어런스 및 단백질질환의 치료
|
|
US9853396B1
(en)
|
2016-12-05 |
2017-12-26 |
Delphi Technologies, Inc. |
Electrical plug having a flexible terminal retention feature
|